| |
Univariate
|
Multivariate
|
|---|
|
Factor
|
P
|
RR
|
95% CI
|
P
|
RR
|
95% CI
|
|---|
|
Age
|
0.67
|
0.882
|
0.494–1.576
| | | |
|
Tumor size
|
0.21
|
1.483
|
0.797–2.759
| | | |
|
Lymph node status
|
0.40
|
0.746
|
0.376–1.479
| | | |
|
Histological grade
|
0.20
|
0.542
|
0.213–1.382
| | | |
|
HER2
|
0.0033*
|
0.340
|
0.166–0.699
| | | |
|
ER-α (1D5)
|
0.0009*
|
2.924
|
1.550–5.515
|
0.0076*
|
2.465
|
1.271–4.781
|
|
ER-α Ser118
|
0.36
|
1.308
|
0.732–2.340
| | | |
|
ER-α Ser167
|
0.035*
|
1.890
|
1.045–3.420
|
0.19
|
1.536
|
0.841–2.900
|
|
ER-β1
|
0.37
|
1.355
|
0.697–2.635
| | | |
|
ER-βcx/β2
|
0.10
|
1.627
|
0.905–2.926
| | | |
|
PR (636)
|
0.0012*
|
2.796
|
1.498–5.220
| | | |
|
PRA
|
0.03*
|
2.182
|
1.202–3.960
| | | |
|
PRB
|
0.013*
|
2.157
|
1.177–3.951
|
0.24
|
1.499
|
0.763–2.945
|
- CI, confidence interval; ER, estrogen receptor; PR, progesterone receptor; RR, relative risk. *P < 0.05.
